The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signalingEmmanuel Laplantine(Centre National de la Recherche Scientifique), Robert Weil(Centre National de la Recherche Scientifique)iScienceSeptember 2, 202210.1016/j.isci.2022.105066Cited by 24SaveCiteExport RISWatch citationsRelated PapersPhosphorylation of Optineurin by protein kinase D regulates Parkin-dependent mitophagy|iScience|2024|3